Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Perspective Therapeutics, Inc. Common Stock (NY:CATX)

4.110 +0.330 (+8.73%)
Official Closing Price Updated: 8:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,086,781
Open 3.740
Bid (Size) 4.000 (1)
Ask (Size) 4.030 (13)
Prev. Close 3.780
Today's Range 3.740 - 4.130
52wk Range 1.600 - 16.55
Shares Outstanding 280,571,026
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INDP),(NYSE:CATX),(NASDAQ:SLS),(NASDAQ:AUTL EQNX::TICKER_END 
Via FinancialNewsMedia
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
Issued on behalf of Oncolytics Biotech Inc. Vancouver, BC – June 18, 2025 – USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer.... 
Via FinancialNewsMedia

Performance

YTD
+24.2%
+24.2%
1 Month
+19.8%
+19.8%
3 Month
+121.0%
+121.0%
6 Month
+17.4%
+17.4%
1 Year
-65.0%
-65.0%

More News

Read More
Earnings Scheduled For May 12, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Top movers in Friday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 26, 2025
Via Benzinga
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
Via Benzinga
Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars
Via Benzinga
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Via Investor's Business Daily
Topics Government
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Via Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Via Benzinga
Topics Stocks
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Via Benzinga
Dow Surges 150 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
Topics Stocks
CATX Stock Earnings: Perspective Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
3 Outperforming Stocks Surpassing Even Nvidia This Year
Via InvestorPlace
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga

Frequently Asked Questions

Is Perspective Therapeutics, Inc. Common Stock publicly traded?
Yes, Perspective Therapeutics, Inc. Common Stock is publicly traded.
What exchange does Perspective Therapeutics, Inc. Common Stock trade on?
Perspective Therapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Perspective Therapeutics, Inc. Common Stock?
The ticker symbol for Perspective Therapeutics, Inc. Common Stock is CATX on the New York Stock Exchange
What is the current price of Perspective Therapeutics, Inc. Common Stock?
The current price of Perspective Therapeutics, Inc. Common Stock is 4.110
When was Perspective Therapeutics, Inc. Common Stock last traded?
The last trade of Perspective Therapeutics, Inc. Common Stock was at 07/10/25 08:00 PM ET
What is the market capitalization of Perspective Therapeutics, Inc. Common Stock?
The market capitalization of Perspective Therapeutics, Inc. Common Stock is 1.15B
How many shares of Perspective Therapeutics, Inc. Common Stock are outstanding?
Perspective Therapeutics, Inc. Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.